| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Center for the Study of Hepatitis C, Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10021;
Department of Molecular Microbiology and Immunology and
Department of Internal Medicine, Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St. Louis, MO 63104; and
Department of Medicine, Division of Gastroenterology and Hepatology, Weill Medical College of Cornell University, New York, NY 10021
Chronic infection with hepatitis C virus (HCV) is associated with disturbances of B lymphocyte activation and function: autoantibody production, mixed cryoglobulinemia, and B cell lymphomas. It has been proposed that these abnormalities reflect chronic antigenic stimulation or aberrant signaling through the B cell coreceptor, the latter mediated by binding of the HCV E2 glycoprotein to CD81. To test this hypothesis, we measured expression of activation and differentiation markers on peripheral blood B cells from patients with chronic HCV infection. Thirty-six HCV patients with and without mixed cryoglobulinemia were compared with 18 healthy control volunteers and 17 sustained virologic responders who had cleared HCV infection. Ten of the 36 HCV patient samples showed increased B cell frequencies; B cell frequency was higher in patients with more severe hepatic fibrosis. However, these samples lacked evidence of Ag-driven activation or proliferation. The expanded cells were low in the activation markers CD25, CD69, CD71, CD80, and CD86. Proliferation of circulating B cells was unchanged in HCV patients. These cells did not express the differentiation marker CD27, suggesting that they were not enriched in memory B cells. Furthermore, the expanded B cells expressed both IgD and IgM, suggesting that they were antigenically naive. Together, these results indicate that B cell expansion in the peripheral blood of HCV patients is not associated with Ag-mediated activation and differentiation. Instead, factors other than antigenic stimulation may promote the accumulation of peripheral blood B cells with a naive phenotype in a subset of HCV patients.
This article has been cited by other articles:
|
|
 |
|
  E. L. Carpenter, R. Mick, A. J. Rech, G. L. Beatty, T. A. Colligon, M. R. Rosenfeld, D. E. Kaplan, K.-M. Chang, S. M. Domchek, P. A. Kanetsky, et al. Collapse of the CD27+ B-Cell Compartment Associated with Systemic Plasmacytosis in Patients with Advanced Melanoma and Other Cancers Clin. Cancer Res., July 1, 2009; 15(13): 4277 - 4287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Sansonno, F. A. Tucci, L. Troiani, G. Lauletta, M. Montrone, V. Conteduca, L. Sansonno, and F. Dammacco Increased serum levels of the chemokine CXCL13 and up-regulation of its gene expression are distinctive features of HCV-related cryoglobulinemia and correlate with active cutaneous vasculitis Blood, September 1, 2008; 112(5): 1620 - 1627. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. D. Charles, R. M. Green, S. Marukian, A. H. Talal, G. V. Lake-Bakaar, I. M. Jacobson, C. M. Rice, and L. B. Dustin Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia Blood, February 1, 2008; 111(3): 1344 - 1356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Lake-Bakaar, L. Dustin, J. McKeating, K. Newton, V. Freeman, and S. D.W. Frost Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease Blood, January 15, 2007; 109(2): 845 - 846. [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Owsianka, J. M. Timms, A. W. Tarr, R. J. P. Brown, T. P. Hickling, A. Szwejk, K. Bienkowska-Szewczyk, B. J. Thomson, A. H. Patel, and J. K. Ball Identification of conserved residues in the e2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding. J. Virol., September 1, 2006; 80(17): 8695 - 8704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Racanelli, M. A. Frassanito, P. Leone, M. Galiano, V. De Re, F. Silvestris, and F. Dammacco Antibody Production and In Vitro Behavior of CD27-Defined B-Cell Subsets: Persistent Hepatitis C Virus Infection Changes the Rules. J. Virol., April 1, 2006; 80(8): 3923 - 3934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Rosa, G. Saletti, E. De Gregorio, F. Zorat, C. Comar, U. D'Oro, S. Nuti, M. Houghton, V. Barnaba, G. Pozzato, et al. Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders PNAS, December 20, 2005; 102(51): 18544 - 18549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Butera, S. Marukian, A. E. Iwamaye, E. Hembrador, T. J. Chambers, A. M. Di Bisceglie, E. D. Charles, A. H. Talal, I. M. Jacobson, C. M. Rice, et al. Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C Blood, August 15, 2005; 106(4): 1175 - 1182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Carbonari, E. Caprini, T. Tedesco, F. Mazzetta, V. Tocco, M. Casato, G. Russo, and M. Fiorilli Hepatitis C Virus Drives the Unconstrained Monoclonal Expansion of VH1-69-Expressing Memory B Cells in Type II Cryoglobulinemia: A Model of Infection-Driven Lymphomagenesis J. Immunol., May 15, 2005; 174(10): 6532 - 6539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Chambers, X. Fan, D. A. Droll, E. Hembrador, T. Slater, M. W. Nickells, L. B. Dustin, and A. M. DiBisceglie Quasispecies Heterogeneity within the E1/E2 Region as a Pretreatment Variable during Pegylated Interferon Therapy of Chronic Hepatitis C Virus Infection J. Virol., March 1, 2005; 79(5): 3071 - 3083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Moir, A. Malaspina, O. K. Pickeral, E. T. Donoghue, J. Vasquez, N. J. Miller, S. R. Krishnan, M. A. Planta, J. F. Turney, J. S. Justement, et al. Decreased Survival of B Cells of HIV-viremic Patients Mediated by Altered Expression of Receptors of the TNF Superfamily J. Exp. Med., September 6, 2004; 200(5): 587 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. H. Sasso, M. Martinez, S. L. Yarfitz, P. Ghillani, L. Musset, J.-C. Piette, and P. Cacoub Frequent Joining of Bcl-2 to a JH6 Gene in Hepatitis C Virus-Associated t(14;18) J. Immunol., September 1, 2004; 173(5): 3549 - 3556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. de Sanjose, A. Dickie, T. Alvaro, V. Romagosa, M. Garcia Villanueva, E. Domingo-Domenech, A. Fernandez de Sevilla, and E. El-Omar Helicobacter pylori and Malignant Lymphoma in Spain Cancer Epidemiol. Biomarkers Prev., June 1, 2004; 13(6): 944 - 948. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
